Matches in Wikidata for { <http://www.wikidata.org/entity/Q89615009> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q89615009 description "article scientifique publié en 2020" @default.
- Q89615009 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89615009 description "scientific article published on 06 February 2020" @default.
- Q89615009 description "wetenschappelijk artikel" @default.
- Q89615009 description "наукова стаття, опублікована 6 лютого 2020" @default.
- Q89615009 name "Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies" @default.
- Q89615009 name "Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies" @default.
- Q89615009 type Item @default.
- Q89615009 label "Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies" @default.
- Q89615009 label "Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies" @default.
- Q89615009 prefLabel "Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies" @default.
- Q89615009 prefLabel "Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies" @default.
- Q89615009 P1433 Q89615009-09F349B9-A489-428C-8158-B5990DEE4818 @default.
- Q89615009 P1476 Q89615009-1B87A28F-ED31-4F14-B393-8A1F0F0DA611 @default.
- Q89615009 P2093 Q89615009-37F64C00-E62B-41EF-BFE4-E03248873652 @default.
- Q89615009 P2093 Q89615009-560C208C-5D65-4B5E-B570-5274884742D0 @default.
- Q89615009 P2093 Q89615009-828C334F-AD10-4B85-9B5A-562F4289E0D4 @default.
- Q89615009 P2093 Q89615009-8FE4B423-8F21-4655-977C-5B01CDAB7FBC @default.
- Q89615009 P2093 Q89615009-958B7939-EE39-43A0-B101-CCE5CAF33A09 @default.
- Q89615009 P2093 Q89615009-9D5B656B-3E67-4D97-A096-DEA5E259EBC1 @default.
- Q89615009 P2093 Q89615009-B5F37202-DD4A-47DC-9BD2-976BC790B522 @default.
- Q89615009 P2093 Q89615009-F70247AB-6A75-461B-BD30-6E7DFDA2CCD8 @default.
- Q89615009 P31 Q89615009-0E72AA19-F566-4216-9110-404A3A33CDAA @default.
- Q89615009 P31 Q89615009-145fe2f2-c8c0-4236-b338-7240919fd96b @default.
- Q89615009 P356 Q89615009-B38AD580-D711-4FA3-A3A5-B680058F449F @default.
- Q89615009 P577 Q89615009-E14EADFF-6284-40A6-9868-3BC795E258A3 @default.
- Q89615009 P698 Q89615009-C5CD216D-2706-4A7B-A231-300151F3AF65 @default.
- Q89615009 P921 Q89615009-0A5B8270-8A00-4032-9AF6-511878AB9BC0 @default.
- Q89615009 P921 Q89615009-69FAFC42-569B-4E16-833B-322B8910B40D @default.
- Q89615009 P356 J.EJCA.2020.01.003 @default.
- Q89615009 P698 32037060 @default.
- Q89615009 P1433 Q332260 @default.
- Q89615009 P1476 "Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies" @default.
- Q89615009 P2093 "Angelo Paci" @default.
- Q89615009 P2093 "Aude Desnoyer" @default.
- Q89615009 P2093 "Christophe Maritaz" @default.
- Q89615009 P2093 "Julia Delahousse" @default.
- Q89615009 P2093 "Louis Blondel" @default.
- Q89615009 P2093 "Nathalie Chaput" @default.
- Q89615009 P2093 "Olivier Mir" @default.
- Q89615009 P2093 "Sophie Broutin" @default.
- Q89615009 P31 Q13442814 @default.
- Q89615009 P31 Q7318358 @default.
- Q89615009 P356 "10.1016/J.EJCA.2020.01.003" @default.
- Q89615009 P577 "2020-02-06T00:00:00Z" @default.
- Q89615009 P698 "32037060" @default.
- Q89615009 P921 Q323936 @default.
- Q89615009 P921 Q725307 @default.